Mirena IUD Health Problems Left Woman With Migraines, Blurry Vision, Nausea, Lawsuit Claims
A Mirena lawsuit claims that the birth control implant caused a woman to suffer migraines, blurry vision and other problems even after it was removed.
Tag Archives: Migraines
-
-
Mirena IUD Injury Settlement May Be Reached During Appeal of Migration, Perforation Cases
A deal has reportedly been reached that could resolve about 1,300 Mirena IUD lawsuits over perforation and migration injuries, court documents indicate.
-
Lawsuit Claims Essure Coil Complications Led To Migraines, Hair Loss, Hysterectomy
A new Essure lawsuit indicates that the birth control implant caused a woman to suffer migraines, hair loss, and forced her to undergo a hysterectomy to have the device removed.
-
Zecuity Migraine Patch Recall Issued While FDA Investigates Burn, Scarring Reports
A Zecuity migraine patch recall follows adverse event reports of scars and burning and an ongoing FDA investigation.
-
Zecuity Migraine Patch May Cause Burns, Scars, FDA Warns
The FDA is warning that it has received numerous reports of consumers burned or scarred where they wore the new Zecuity migraine patch.
-
Researchers Raise Doubts About Benefits of Migraine Surgery
Researchers suggest that surgery to treat migraines not provide real benefits.
-
Brain Scans Overused For Headache Exams, Despite Guidelines: Study
Doctors are prescribing unnecessary MRIs to analyze headache reports, a new study finds.
-
Depakote Birth Defects Lawsuit Filed Over Congenital Malformations
Abbott Laboratories faces a product liability lawsuit brought by a California woman who indicates that she gave birth to three children who suffered birth defects and congenital malformations that were…
-
Depakote Pregnancy Risk Leads To New FDA Restrictions
According to a new warning issued by federal drug regulators, pregnant women should not use certain epilepsy drugs to treat migraines, due to a potential risk that drugs like Depakote…
-
Neurontin Lawsuit Verdict of $142M Upheld By Appeals Court
A federal appeals court has upheld a $142 million jury verdict in a case involving Pfizer’s epilepsy drug Neurontin, and opened the door for potentially even more lawsuits.
